3D Printed vs Ready-to-Wear Insoles for Diabetic Neuropathy
Key facts
- Who runs it
- University of Faisalabad
- Where
- Pakistan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 22 people, planned
- Started
- 1 Jan 2026
- Ended
- 15 Jul 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 3D Printed Customized Insole
- Ready-to-Wear Insole
- Record updated
- 17 June 2026
Who can take part
- Age
- 35 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (16)Hide the full registry criteria
Who can take part
- Age 35 to 65 years
- Diagnosed with diabetes mellitus
- Clinical diagnosis of diabetic peripheral neuropathy
- Ability to walk independently without walking aids
- Normal cognitive function
- Corrected or uncorrected vision sufficient for safe ambulation
- Willingness to provide written informed consent
Who cannot take part
- Presence of active foot ulcer
- History of lower limb surgery within past 6 months
- Peripheral vascular disease
- Neuromuscular diseases (e.g., stroke, Parkinson's disease, multiple sclerosis)
- External wound on lower extremity
- Major lower limb amputation
- Foot drop
- Charcot arthropathy
- Inability to comply with study protocol
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Diabetic neuropathy is a condition caused by chronic high blood glucose levels that damage nerves over time, frequently causing abnormal plantar pressure and increasing the risk of foot ulcers and impaired mobility. Insoles are widely used to redistribute pressure and improve comfort. This study compares the effect of 3D printed customized insoles versus ready-to-wear insoles on plantar pressure changes in patients with diabetic neuropathy. The study is a randomized controlled trial with 22 participants randomly allocated to two groups: one receiving 3D printed customized insoles and the other receiving ready-to-wear insoles. Plantar pressure is measured using piezoresistive sensors and an Arduino Nano Unit. Secondary outcomes include foot health status (FSHQ questionnaire), satisfaction with assistive technology (QUEST 2.0), and neuropathy severity (NSS and NDS questionnaires). Assessments occur at baseline, 4 weeks, and 8 weeks.
The 2 groups in the trial
- Group A: 3D Printed Customized InsolesTreatment being tested
Participants in this group receive 3D printed customized insoles tailored to individual foot morphology. Insoles are designed to provide arch support and gait alignment. Participants wear insoles for minimum 6 hours/day, 5 days/week for 8 weeks, following a phased protocol of acclimatization, pressure adaptation, and function improvement.
Treatment: 3D Printed Customized Insole and Ready-to-Wear Insole
- Group B: Ready-to-Wear InsolesExisting treatment, for comparison
Participants in this group receive prefabricated ready-to-wear insoles providing general cushioning and basic support. Participants wear insoles for minimum 6 hours/day, 5 days/week for 8 weeks, following the same phased protocol as the experimental group.
Treatment: Ready-to-Wear Insole
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparative Effect of 3D Printed Customized Insoles and Ready to Wear Insoles on Plantar Pressure Changes in Patients With Diabetic Neuropathy
- Record updated
- 17 June 2026